Domains featuring this topic
Explore the domains where this topic appears.
Nature staff discuss how a newly approved orexin-targeting narcolepsy drug could enable therapies for other neurological conditions, and examine human brain organoids that have remained viable for more than five years. The episode connects sleep medicine, therapeutic neuroscience, and long-term models of human brain development.
We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.